Rupali Jain
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antifungal resistance and susceptibility 9
- Antimicrobial Resistance in Staphylococcus 8
- Epidemiology 22
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Urinary Tract Infections Management 5
- Co-authors
- Larry H. Danziger (5 shared papers)Paul S. Pottinger (19 shared papers)Robert M. Rakita (6 shared papers)David N. Fredricks (3 shared papers)Shahin Hakimian (1 shared paper)Ayesha Appa (1 shared paper)Helen Y. Chu (2 shared papers)Samuel L Aitken (3 shared papers)
- Journals
- Open Forum Infectious Diseases (11 papers)Infection Control and Hospital Epidemiology (5 papers)Clinical Infectious Diseases (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)Journal of the National Comprehensive Cancer Network (2 papers)
- Partner nations
- United StatesSouth AfricaBelgium
In The Last Decade
Rupali Jain
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Applied Microbiology and Biotechnology 144
- Molecular Medicine 335
- Infectious Diseases 412
- Pharmacology 322
- Endocrinology 79
Countries citing papers authored by Rupali Jain
This map shows the geographic impact of Rupali Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Jain more than expected).
Fields of papers citing papers by Rupali Jain
This network shows the impact of papers produced by Rupali Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Jain. The network helps show where Rupali Jain may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupali Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 177 | |
| 2 | 2017 | 106 | |
| 3 | 2004 | 96 | |
| 4 | 2017 | 83 | |
| 5 | 2017 | 71 | |
| 6 | 2013 | 63 | |
| 7 | 2006 | 49 | |
| 8 | 2014 | 45 | |
| 9 | 2016 | 41 | |
| 10 | 2015 | 41 | |
| 11 | 2014 | 36 | |
| 12 | 2020 | 30 | |
| 13 | 2013 | 26 | |
| 14 | 2017 | 26 | |
| 15 | 2017 | 25 | |
| 16 | 2015 | 20 | |
| 17 | 2007 | 17 | |
| 18 | 2016 | 13 | |
| 19 | Electronic Surveillance For Catheter-Associated Urinary Tract Infection Using Natural Language Processing. | 2017 | 11 |
| 20 | 2019 | 11 |
About Rupali Jain
Rupali Jain is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Applied Microbiology and Biotechnology and Oncology, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Bacterial Identification and Susceptibility Testing (11 papers), Antifungal resistance and susceptibility (9 papers), Neutropenia and Cancer Infections (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (144 citations), Molecular Medicine (335 citations), Infectious Diseases (412 citations), Pharmacology (322 citations) and Endocrinology (79 citations). Rupali Jain has collaborated with scholars based in United States, South Africa and Belgium. Frequent co-authors include Larry H. Danziger, Paul S. Pottinger, Robert M. Rakita, David N. Fredricks, Shahin Hakimian, Ayesha Appa, Helen Y. Chu, Samuel L Aitken, Hu Xie and John B. Lynch. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.